RNA in vitro transcription is a laboratory method that uses a DNA template and a phage RNA polymerase to synthesize RNA outside of a cell. You provide a linear DNA template containing a promoter sequence, the four ribonucleotide triphosphates (NTPs), and the enzyme, and the reaction produces a defined RNA transcript that can be used for research, diagnostics, or therapeutic development.
Formula
The theoretical maximum yield of RNA is calculated by converting the mass of template DNA into moles, then multiplying by the number of RNA copies produced per template (typically 1 for a linear template), the length of the transcript, and the average molecular weight of an NTP. In symbols:
RNA mass (µg) = (mDNA / 1000) × (n × MWNTP) / NA × NA / 106
Where:
- mDNA = mass of template DNA (µg)
- n = length of the RNA transcript (nucleotides, nt)
- MWNTP = average molecular weight of a ribonucleotide monophosphate in the RNA (g/mol). The default 330 g/mol is a common average for the free acid of an NMP (adenosine, guanosine, cytidine, uridine monophosphates).
- NA = Avogadro constant, 6.022 × 1023 mol−1.
This gives the absolute maximum if every template molecule is transcribed once and every RNA product is recovered. Actual yields are typically 10–50% of this value due to incomplete reactions, degradation, and losses during purification.
Worked Example
Using the default values from the calculator: 1 µg of a 1000-nt template, with an average NTP molecular weight of 330 g/mol.
- Convert template mass to grams: 1 µg = 1 × 10−6 g.
- Moles of template = 1 × 10−6 g / (1000 nt × 330 g/mol) = 1 × 10−6 / 330,000 = 3.0303 × 10−12 mol.
- Assuming 1 RNA copy per template, moles of RNA = 3.0303 × 10−12 mol.
- Mass of RNA = moles × MW = 3.0303 × 10−12 mol × (1000 × 330 g/mol) = 3.0303 × 10−12 × 330,000 = 1.00 × 10−6 g = 1.00 µg.
The calculator returns 1.00 µg. Note that the theoretical yield equals the input mass when the transcript length equals the template length, because each nucleotide added has the same average mass as the template nucleotide. In practice, the reaction does not go to completion, so you would expect less.
Assumptions
- Each template DNA molecule is transcribed exactly once (no re-initiation).
- The template is linear and contains a strong promoter recognized by the chosen RNA polymerase.
- The RNA product is perfectly stable and recovered with 100% efficiency.
- The average molecular weight of the four NMPs is 330 g/mol; actual values range from 305 (U) to 345 (G) g/mol.
- No RNA degradation occurs during the reaction or purification.
Background: What Is In Vitro Transcription?
In vitro transcription (IVT) is a cell-free reaction that copies a DNA sequence into RNA using a purified RNA polymerase. The most common enzymes are the bacteriophage T7, T3, and SP6 RNA polymerases, each recognizing its own specific promoter sequence. These polymerases are highly processive and do not require additional transcription factors, making them ideal for laboratory use.
IVT is used to produce RNA for many applications:
- Ribozyme and aptamer research
- mRNA for transfection and vaccine development
- RNA interference (siRNA, shRNA) precursors
- RNA for structural studies (crystallography, cryo-EM)
- RNA probes for in situ hybridization and Northern blotting
- Non-coding RNA for functional studies
The reaction is simple: mix a linear DNA template containing the promoter upstream of the gene of interest, NTPs (ATP, CTP, GTP, UTP), a buffer with magnesium, and the RNA polymerase. Incubate at 37 °C for 1–4 hours, then treat with DNase to remove the template, and purify the RNA.
How It Works: The Reaction Steps
The IVT reaction proceeds in three stages:
- Initiation: The RNA polymerase binds to the double-stranded promoter region on the DNA template. The promoter is typically 17–23 base pairs long. For T7 RNA polymerase, the consensus promoter is TAATACGACTCACTATAGGG, where the underlined G is the first nucleotide incorporated into RNA.
- Elongation: The polymerase unwinds the DNA, reads the template strand in the 3′→5′ direction, and adds complementary ribonucleotides to the growing RNA chain in the 5′→3′ direction. The reaction requires Mg²⁺ as a cofactor, and the NTPs are consumed at a rate of ~200–400 nt/s.
- Termination: The polymerase falls off when it reaches the end of the linear DNA template. Unlike cellular RNA polymerases, phage polymerases do not require a specific termination signal; they simply stop at the end of the template. This is why the template must be linearized downstream of the gene of interest.
The reaction buffer typically contains 40 mM Tris-HCl (pH 7.5–8.0), 6 mM MgCl₂, 10 mM DTT, 2 mM spermidine, and 1–2 mM of each NTP. The optimal temperature is 37 °C for T7 and T3, and 40 °C for SP6. The template DNA is usually used at a concentration of 20–50 ng/µL.
Choosing a Promoter and Template Design
The choice of RNA polymerase determines the promoter sequence you must include in your DNA template. The three most common are:
- T7 promoter: TAATACGACTCACTATAGGG (most widely used, high yield)
- T3 promoter: AATTAACCCTCACTAAAGGG
- SP6 promoter: ATTTAGGTGACACTATAGAA
The template can be a PCR product, a plasmid linearized with a restriction enzyme, or a synthetic DNA fragment. For PCR templates, the promoter is added as part of the forward primer. The template must be linear; supercoiled plasmid is inefficient because the polymerase stalls on circular DNA. After linearization, it is essential to purify the DNA to remove restriction enzymes and salts, and to ensure the end is flush or 5′ overhang (3′ overhangs can cause run-on transcripts).
If you need a cap on the RNA (for mRNA vaccines or translation), you have two options: add a cap analog (e.g., m7GpppG) to the reaction at a 4:1 ratio of cap analog to GTP, or use a post-transcriptional capping enzyme. For a poly(A) tail, you can either include it in the template or use a separate poly(A) polymerase reaction.
Common Problems and Troubleshooting
Several issues can reduce yield or quality:
- Low yield: Check the template concentration and purity. A common cause is residual ethanol or salt from DNA purification. Increase the reaction time or add more polymerase. Also ensure the NTPs are not degraded (store at −20 °C, avoid repeated freeze-thaw).
- Abortive transcripts: Short, truncated products are common at the initiation stage. They appear as a ladder below the full-length band on a gel. This is normal; the full-length product can be gel-purified.
- RNA degradation: RNases are everywhere. Use RNase-free water and tubes, wear gloves, and treat surfaces with RNase decontamination solutions. Include an RNase inhibitor (e.g., RNasin) in the reaction.
- Precipitation of DNA template: Spermidine in the buffer can precipitate DNA at low temperatures. Add the DNA last and keep the reaction at room temperature before incubation.
- Incomplete linearization: If the restriction digest is incomplete, you will get longer transcripts. Run the digest to completion and check on a gel.
A simple way to check the reaction is to run a small aliquot on an agarose gel. The RNA should appear as a distinct band at the expected size. If you see a smear, degradation may have occurred.
Yield, Purity, and Analysis
Typical IVT reactions yield 50–200 µg of RNA per 20 µL reaction, depending on the template length and polymerase. The theoretical maximum from 1 µg of a 1000-nt template is 1 µg, but with optimized conditions, you can often achieve 80% of that. For longer transcripts (>5000 nt), yields are lower due to increased degradation and polymerase stalling.
After the reaction, you must remove the DNA template by adding DNase I (RNase-free) and incubating for 15 minutes at 37 °C. Then purify the RNA using a column-based kit or lithium chloride precipitation. The purity can be assessed by UV spectrophotometry: the A260/A280 ratio should be ~2.0 for RNA. The concentration can be measured by absorbance (1 A260 unit = 40 µg/mL RNA) or by a fluorometric assay.
For applications requiring high purity, such as mRNA vaccines, additional purification steps like HPLC or cellulose-based chromatography are used to remove double-stranded RNA byproducts, which can trigger innate immune responses.
Safety and Best Practices
In vitro transcription is a routine molecular biology procedure, but it requires care to avoid RNase contamination and to handle reagents safely. Always follow your lab method, the safety data sheet (SDS) for each reagent, and your supervisor’s instructions. Key points:
- Wear gloves and use dedicated RNase-free consumables.
- NTPs are irritants; avoid inhalation and skin contact.
- DTT and spermidine are harmful if ingested; handle in a fume hood if possible.
- DNase I is an enzyme that can cause allergic reactions; avoid aerosolization.
- Dispose of any RNA-containing waste according to your institution’s guidelines.
The calculator above gives a theoretical maximum yield based on template mass and transcript length. It does not account for reaction efficiency, degradation, or purification losses, so treat the result as an upper bound.
Frequently Asked Questions
What is the difference between in vitro transcription and reverse transcription?
In vitro transcription synthesizes RNA from a DNA template using RNA polymerase. Reverse transcription synthesizes DNA from an RNA template using reverse transcriptase. They are opposite directions of the central dogma. IVT is used to make RNA probes or mRNA, while reverse transcription is used to make cDNA for cloning or qPCR.
Can I use a plasmid as the template directly?
Yes, but the plasmid must be linearized with a restriction enzyme downstream of the insert. Supercoiled plasmid is a poor template because the polymerase cannot efficiently transcribe around the circle. After linearization, purify the DNA to remove the restriction enzyme and salts.
How do I add a 5′ cap to my RNA?
You can add a cap analog (such as m7GpppG) to the IVT reaction. The cap analog is included at a 4:1 molar ratio to GTP, and the polymerase incorporates it at the 5′ end. Alternatively, you can use a capping enzyme after transcription. For mRNA vaccines, the cap is essential for translation and stability.
Why is my RNA yield so low?
Common causes include: template DNA contaminated with salts or ethanol, degraded NTPs, insufficient polymerase, or RNase contamination. Check the template concentration by gel, use fresh NTPs, increase the polymerase amount, and ensure all solutions are RNase-free. Also, verify that the promoter sequence is correct and the template is linear.
What is the best way to purify the RNA after transcription?
For most applications, a column-based RNA purification kit is convenient and removes NTPs, salts, and enzymes. For longer RNA or high purity, lithium chloride precipitation works well. For mRNA vaccines, additional purification to remove double-stranded RNA is necessary, often using HPLC or cellulose chromatography.
Can I make RNA with modified nucleotides?
Yes. Many modified NTPs (e.g., pseudouridine, N1-methylpseudouridine, 5-methylcytidine) are commercially available and are incorporated efficiently by T7 RNA polymerase. These modifications are used in mRNA therapeutics to reduce immunogenicity and increase stability.
Related
Formula used
in m | Template DNA amount | µg | 1 | 0 in n | Transcript length | nt | 1000 | 1 in mm | NTP average MW | g/mol | 330 | 1 out y | RNA yield (theoretical) | µg | m / 1000 * n * mm / 6.02214076e23 * 6.02214076e23 / 1e6 | 2 out nmol | RNA amount | nmol | y / (n * mm) * 1000 | 2
Each line is one input (in, sel, list) or one result (out: label, unit, formula, decimals). How the calculators work
Method: the standard formula for this calculation with the constants and conversion factors written on the page, rounded as each result states. See method and constants, the disclaimer or report an error.
More in this section
- Normality to meq/mL Conversion Calculator1.0000 meq/mL
- Normality to g/L Converter & Formula29.220 g/L
- Normality Test Q-Q Plot: How to Read It
- Normality Test Results: How to Analyze Them
- Normality Slay the Spire?
- Normality Test for Paired t Test: How to Check